HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by King, R. M. Articles by Bernatz, P. E. Search for Related Content PubMed PubMed Citation Articles by King, R. M. Articles by Bernatz, P. E.

The Annals of Thoracic Surgery, Vol 44, 119-122, Copyright © 1987 by The Society of Thoracic Surgeons

ARTICLES

Ivor Lewis esophagogastrectomy for carcinoma of the esophagus: early and late functional results

RM King, PC Pairolero, VF Trastek, WS Payne and PE Bernatz

One hundred adult patients underwent Ivor Lewis esophagogastrectomy for documented carcinoma of the esophagus from 1980 through 1982. After operation, 7 patients were classified in Stage I, 11 in Stage II, and 82 in Stage III. Major postoperative complications occurred in 27 patients and included pulmonary problems in 11, suture line leak in 9, wound infection in 5, empyema in 4, renal failure in 4, abdominal abscess in 4, bleeding in 2, myocardial infarction in 2, and chylothorax in 1. There were 3 deaths within 30 days of operation. Five- year survival was 85.7% for patients with Stage I disease, 34.1% for patients with Stage II disease (p = .052), and 15.2% for patients with Stage III disease (p = .001). Late morbidity included weight loss in 60 patients, dysphagia in 40, gastroesophageal reflux in 14, and gastroduodenal dumping in 5. Thirty-one patients required postoperative esophageal dilations (mean, 3.4). Most patients, however, were eating without dysphagia at the time of last follow-up or death. We conclude that the Ivor Lewis esophagogastrectomy can be performed with low mortality, can provide adequate palliation, and does result in satisfactory long-term survival for those patients with more favorable postsurgical stages of cancer. These results support the continued use of the Ivor Lewis esophagogastrectomy for treatment of carcinoma of the esophagus.

This article has been cited by other articles:

				M. Arnold, A. Mura, W. Langhans, and N. Geary Gut Vagal Afferents Are Not Necessary for the Eating-Stimulatory Effect of Intraperitoneally Injected Ghrelin in the Rat J. Neurosci., October 25, 2006; 26(43): 11052 - 11060. [Abstract] [Full Text] [PDF]

				C. W. le Roux, N. M. Neary, T. J. Halsey, C. J. Small, A. M. Martinez-Isla, M. A. Ghatei, N. A. Theodorou, and S. R. Bloom Ghrelin Does Not Stimulate Food Intake in Patients with Surgical Procedures Involving Vagotomy J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4521 - 4524. [Abstract] [Full Text] [PDF]

				R. J. Downey, T. Akhurst, D. Ilson, R. Ginsberg, M. S. Bains, M. Gonen, H. Koong, M. Gollub, B. D. Minsky, M. Zakowski, et al. Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial J. Clin. Oncol., February 1, 2003; 21(3): 428 - 432. [Abstract] [Full Text] [PDF]

				S. H. Kim, K. S. Lee, Y. M. Shim, K. Kim, P. S. Yang, and T. S. Kim Esophageal Resection: Indications, Techniques, and Radiologic Assessment RadioGraphics, September 1, 2001; 21(5): 1119 - 1137. [Abstract] [Full Text] [PDF]

				A. L. Visbal, M. S. Allen, D. L. Miller, C. Deschamps, V. F. Trastek, and P. C. Pairolero Ivor Lewis esophagogastrectomy for esophageal cancer Ann. Thorac. Surg., June 1, 2001; 71(6): 1803 - 1808. [Abstract] [Full Text] [PDF]

				A. J. McLarty, C. Deschamps, V. F. Trastek, M. S. Allen, P. C. Pairolero, and W. S. Harmsen Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Ann. Thorac. Surg., June 1, 1997; 63(6): 1568 - 1571. [Abstract] [Full Text]

				F. H. Ellis Jr., G. J. Heatley, M. J. Krasna, W. A. Williamson, and K. Balogh ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 836 - 848. [Abstract] [Full Text]

				K. W. Millikan, J. Silverstein, V. Hart, K. Blair, S. Bines, J. Roberts, and A. Doolas A 15-Year Review of Esophagectomy for Carcinoma of the Esophagus and Cardia Arch Surg, June 1, 1995; 130(6): 617 - 624. [Abstract] [PDF]

				J. H. Peters, W. K. H. Kauer, P. F. Crookes, A. P. Ireland, C. G. Bremner, and T. R. DeMeester Esophageal Resection With Colon Interposition for End-Stage Achalasia Arch Surg, June 1, 1995; 130(6): 632 - 637. [Abstract] [PDF]

				W. T. Vigneswaran, V. F. Trastek, P. C. Pairolero, C. Deschamps, R. C. Daly, and M. S. Allen Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 901 - 907. [Abstract] [Full Text]